Other Publications
Highly cytotoxic T cells
Jilek et al., CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis, Clin Immunol 2007 Apr;123(1):105-13
Kronenberg et al., Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells, Diabetes 2012 Jul;61(7):1752-9
Dolff et al., Urinary T cells in active lupus nephritis show an effector memory phenotype, Ann Rheum Dis 2010 Nov;69(11):2034-41
Coles et al., Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomized controlled phase 3 trial, Lancet 2012 Nov 24;380(9856):1829-39
Gold et al., Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study, J Neurol 2020 Oct;267(10):2851-2864
Dalakas et al., Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis, Brain 2009 Jun;132(Pt 6):1536-44
KLRG1
Goyal et al., Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells, Neurology 2022 Mar 29;98(13):e1374-e1383, ACR 2020 Poster
Knauss et al., PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited, Neurol Neuroimmunol Neuroinflamm 2019 Apr 10;6(3):e558
Akbar & Henson, Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?, Nat Rev Immunol 2011 Apr;11(4):289-95
Ulviprubart
Pereira et al., The “less-is-more” in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity, MAbs 2018 Jul;10(5):693-711
IBM
Shelly et al., Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study, Neurology 2021 May 25;96(21):e2653-e2661
T-LGLL
Shah et al., A population-based study of large granular lymphocyte leukemia, Blood Cancer J, 2016 Aug 5;6(8):e455
Dinmohamed et al., Population-based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013, Leukemia, 2016 Jun;30(6):1449-51
